Bill C-56, a new and inevitably controversial piece of proposed legislation, was introduced on March 1, 2013. With the short title, Combating Counterfeit Products Act, the message seems simple, but…
Tag: Ryan Heighton (IPilogue Editor)
in Access to Medicines, Competition, Human Rights, IP, Patent Practice, Patentability, Patents1by Editor
985
The ‘Myriad’ with the Golden ‘Gene’: Australia Upholds Breast Cancer Gene Patents
The Myriad Genetics gene patenting saga has officially shaped international jurisprudence, with the Federal Court of Australia upholding the patents for BRCA1 and BRCA2. In Cancer Voices Australia v. Myriad…
'Osgoode Style' Wins Big at 2013 Harold G. Fox Canadian Intellectual Property Moot
It is my pleasure to return to my editorial duties (sans a 007 title pun) for the IPilogue to bring a first hand account of the fifth annual Harold G.…
in Blogs, Commercialization, Competition, European Union, Human Rights, Innovation, Patent Practice, Patentability, Patents, Regulatory Policy, Trade Secrets, US2by Editor
3396
Live and Let Die: Gene Patenting Plot Thickens as the Patent/Trade Secret Line is Blurred
The long battle in the American courts over Myriad Genetics’ patents of BRCA1 and BRCA2, the primary diagnostic genes for hereditary breast and ovarian cancer has been well-documented in the…
in Copyright, defamation, Freedom of Speech, Freedom of the Press, Human Rights, Human Rights Issues, Infringement, Originality1by Editor
1121
The “Word” Is Not Enough: New Cybercrime Prevention Act Leaves Philippine Plagiarists Criminally Vulnerable (UPDATED)
The institution of a controversial new Cybercrime Prevention Act in the Philippines may leave plagiarists subject to criminal sanctions. The penalty for the plagiarism depends on the number of prior…
Diamonds are Forever: New Diamond Patents May Influence Market Development
The extremely variable pricing of diamonds has made them a historically difficult and unstable commodity to trade. However, recent advents in diamond technology have been patented, and industry insiders such…